Side-by-side comparison of AI visibility scores, market position, and capabilities
2024 Revenue: KRW 107.45T (+7.7%) | Operating Profit: KRW 12.67T (+9.1%), margin 11.8% | Global Sales: 3.089M units | Electrified Vehicles: 638k (+10.9%), 21.4% of sales | Highest profit margin among global automakers (vs Tesla, Toyota, Mercedes, BMW, VW) | 2025 guidance: Revenue KRW 112.5T (+4.7%), 3.22M units, Op Profit KRW 12.4T (11% margin)
Kia is a South Korean automotive manufacturer producing a diverse range of vehicles from sedans and SUVs to electric vehicles with an emphasis on value, design, and warranty coverage. The company serves mass-market consumers worldwide who seek well-designed, feature-rich vehicles at competitive prices backed by strong warranties and improving quality. Kia has transformed its brand perception through award-winning designs, improved quality and reliability, industry-leading warranty programs, aggressive expansion into electric vehicles, and a focus on delivering modern styling and technology that rivals premium brands at accessible price points.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.